
    
      The trial will last for six months. Patients will be collected clinical and anthropometric
      data by using questionnaires initially. Patients will have the pulmonary function test and CT
      scan and conduct 6MWT every two months. And Borg scale data will be collected every two
      months. The application of EPAP (15cmH2O) via face mask will be randomized with the help of
      opaque envelopes.
    
  